GME three-lens brief
Evidence-based stock research on GME. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Negative free cash flow last quarterly (-$1.26B).
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Negative free cash flow last quarterly (-$1.26B).
GME closed at $21.84 (-0.50%) as of 2026-07-10. Market cap: $9.80B. P/E (trailing) 16.3. Price is below the 50-day MA and below the 200-day MA. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; negative free cash flow last quarterly (-$1.26B).. Last quarter: Revenue $821.00M, net income $0.00, free cash flow -$1.26B.
Why three lenses on GME, not one.
A single reasoning model has blind spots it doesn’t know about. We examine GMEacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/GME" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath GME brief"></iframe>